Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
2.240
+0.020 (0.90%)
At close: Feb 21, 2025, 4:00 PM
2.230
-0.010 (-0.45%)
After-hours: Feb 21, 2025, 7:49 PM EST
Inovio Pharmaceuticals Stock Forecast
INO's stock price has decreased by -72.58% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Inovio Pharmaceuticals stock have an average target of 17, with a low estimate of 3.00 and a high estimate of 40. The average target predicts an increase of 658.93% from the current stock price of 2.24.
Analyst Consensus: Buy
* Price targets were last updated on Jan 13, 2025.
Analyst Ratings
The average analyst rating for Inovio Pharmaceuticals stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +33.93% | Jan 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +703.57% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $12 → $5 | Hold | Maintains | $12 → $5 | +123.21% | Nov 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $33 → $15 | Buy | Maintains | $33 → $15 | +569.64% | Nov 18, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +167.86% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
126.76K
from 832.01K
Decreased by -84.77%
Revenue Next Year
2.62M
from 126.76K
Increased by 1,970.14%
EPS This Year
-4.25
from -6.09
EPS Next Year
-2.95
from -4.25
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 210,000 | 16.0M | 61.6M | |||
| Avg | 126,755 | 2.6M | 26.8M | |||
| Low | 98,000 | n/a | 9.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -74.8% | 12,483.3% | 2,247.3% | |||
| Avg | -84.8% | 1,970.1% | 922.4% | |||
| Low | -88.2% | - | 271.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -4.00 | -2.15 | -1.31 | |||
| Avg | -4.25 | -2.95 | -2.12 | |||
| Low | -4.61 | -4.36 | -3.34 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.